Evidence map›Paper›PMID 33115723›Full record

ReviewClinical microbiology reviews2020

State of the Art in the Culture of the Human Microbiota: New Interests and Strategies.

Maryam Tidjani Alou, Sabrina Naud, Saber Khelaifia, Marion Bonnet, Jean-Christophe Lagier, Didier Raoult

Abstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Rapid diagnosis of urinary tract infection with miniaturised point-of-care cultivation on a dipstick.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maryam Tidjani AlouAix-Marseille Université, IRD, MEPHI, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.
Sabrina NaudAix-Marseille Université, IRD, MEPHI, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.
Saber KhelaifiaAix-Marseille Université, IRD, MEPHI, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.
Marion BonnetAix-Marseille Université, IRD, MEPHI, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.
Jean-Christophe LagierAix-Marseille Université, IRD, MEPHI, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.
Didier RaoultAix-Marseille Université, IRD, MEPHI, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France didier.raoult@gmail.com.ORCID 0000-0002-0633-5974

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The last 5 years have seen a turning point in the study of the gut microbiota with a rebirth of culture-dependent approaches to study the gut microbiota. High-throughput methods have been developed to study bacterial diversity with culture conditions aimed at mimicking the gut environment by using rich media such as YCFA (yeast extract, casein hydrolysate, fatty acids) and Gifu anaerobic medium in an anaerobic workstation, as well as media enriched with rumen and blood and coculture, to mimic the symbiosis of the gut microbiota. Other culture conditions target phenotypic and metabolic features of bacterial species to facilitate their isolation. Preexisting technologies such as next-generation sequencing and flow cytometry have also been utilized to develop innovative methods to isolate previously uncultured bacteria or explore viability in samples of interest. These techniques have been applied to isolate CPR (Candidate Phyla Radiation) among other, more classic approaches. Methanogenic archaeal and fungal cultures present different challenges than bacterial cultures. Efforts to improve the available systems to grow archaea have been successful through coculture systems. For fungi that are more easily isolated from the human microbiota, the challenge resides in the identification of the isolates, which has been approached by applying matrix-assisted laser desorption ionization-time of flight mass spectrometry technology to fungi. Bacteriotherapy represents a nonnegligible avenue in the future of medicine to correct dysbiosis and improve health or response to therapy. Although great strides have been achieved in the last 5 years, efforts in bacterial culture need to be sustained to continue deciphering the dark matter of metagenomics, particularly CPR, and extend these methods to archaea and fungi.

Indexed as

BacteriaBacteriological TechniquesCulture MediaFlow CytometryGastrointestinal MicrobiomeHumansCulture Mediaarchaeabacteriaculture strategiesculturomicsfungihuman microbiota

Identifiers

PMID33115723
PMCPMC7605308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.